Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Endocrinology

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2008-0857PMID 18669594PMCID PMC2584580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ins and outs of GPR30: a transmembrane estrogen receptor.

  2008cited by this paper
• Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.

  2008cited by this paper
• Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells

  2007cited by this paper
• Human and murine granzyme B exhibit divergent substrate preferences

  2007cited by this paper
• Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma

  2007cited by this paper
• Human and murine granzyme B exhibit divergent substrate preferences.

  2007cited by this paper
• Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.

  2007cited by this paper
• Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis

  2007cited by this paper
• Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.

  2006cited by this paper
• Altered target gene regulation controlled by estrogen receptor-alpha concentration.

  2006cited by this paper
• Altered Target Gene Regulation Controlled by Estrogen Receptor-α Concentration

  2006cited by this paper
• Estrogen receptors and human disease.

  2006cited by this paper
• The major human and mouse granzymes are structurally and functionally divergent

  2006cited by this paper
• Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells.

  2006cited by this paper
• Selective estrogen receptor modulators and prevention of invasive breast cancer.

  2006cited by this paper
• Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.

  2006cited by this paper
• Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens

  2006cited by this paper
• Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma

  2005cited by this paper
• Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells.

  2005cited by this paper
• Soy processing influences growth of estrogen-dependent breast cancer tumors.

  2004cited by this paper
• Interplay between Estrogen Response Element Sequence and Ligands Controls in Vivo Binding of Estrogen Receptor to Regulated Genes*

  2004cited by this paper
• The immunobiology of cancer immunosurveillance and immunoediting.

  2004cited by this paper
• Granzyme B-mediated apoptosis – the elephant and the blind men?

  2004cited by this paper
• Increases in estrogen receptor‐α concentration in breast cancer cells promote serine 118/104/106‐independent AF‐1 transactivation and growth in the absence of estrogen

  2004cited by this paper
• Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.

  2004cited by this paper
• Nuclear war: the granzyme A-bomb.

  2003cited by this paper
• Soy, isoflavones, and breast cancer risk in Japan.

  2003cited by this paper
• ALK‐negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects–a review

  2003cited by this paper
• Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.

  2003cited by this paper
• Lymphocyte-mediated cytotoxicity.

  2003cited by this paper
• Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.

  2002cited by this paper
• Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.

  2002cited by this paper
• Modulators of Inflammation Use Nuclear Factor-κB and Activator Protein-1 Sites to Induce the Caspase-1 and Granzyme B Inhibitor, Proteinase Inhibitor 9*

  2002cited by this paper
• American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

  2002cited by this paper
• The phytoestrogen genistein induces thymic and immune changes: A human health concern?

  2002cited by this paper
• Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner.

  2001cited by this paper
• A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1).

  2001cited by this paper
• Cross-species and interassay comparisons of phytoestrogen action.

  2001cited by this paper
• Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

  2001cited by this paper
• Genistein blocks breast cancer cells in the G2M phase of the cell cycle

  2000cited by this paper
• Dietary isoflavones: biological effects and relevance to human health.

  1999cited by this paper
• Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones.

  1998cited by this paper
• Immune Pathogenesis of Hepatocellular Carcinoma

  1998cited by this paper
• Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo.

  1998cited by this paper
• The Effective Free Fraction of Estradiol and Xenoestrogens in Human Serum Measured by Whole Cell Uptake Assays: Physiology of Delivery Modifies Estrogenic Activity

  1998cited by this paper
• Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

  1997cited by this paper
• Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand.

  1996cited by this paper
• Molecular effects of genistein on estrogen receptor mediated pathways.

  1996cited by this paper
• Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells.

  1994cited by this paper
• Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.

  1989cited by this paper
• Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.

  1989cited by this paper
• Genistein, a specific inhibitor of tyrosine-specific protein kinases.

  1987cited by this paper
• Changes in Circulating Steroids with Aging in Postmenopausal Women

  1981cited by this paper
• Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice.

  1980cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper

• Soy and Isoflavones: Revisiting Their Potential Links to Breast Cancer Risk

  2025cites this paper
• The biological function of Serpinb9 and Serpinb9-based therapy

  2024cites this paper
• Genistein in focus: pharmacological effects and immune pathway modulation in cancer

  2024cites this paper
• Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases

  2024cites this paper
• Understanding the phytoestrogen genistein actions on breast cancer: Insights on estrogen receptor equivalence, pleiotropic essence and emerging paradigms in bioavailability modulation.

  2023cites this paper
• SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response

  2022cites this paper
• Tumor immunomodulatory effects of polyphenols

  2022cites this paper
• Estradiol initiates the immune escape of non-small cell lung cancer cells via ERβ/SIRT1/FOXO3a/PD-L1 axis.

  2022cites this paper
• Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour

  2021cites this paper
• Insights into phenolic compounds from microalgae: structural variety and complex beneficial activities from health to nutraceutics

  2021cites this paper
• Overview of serpin B9 and its roles in cancer (Review).

  2021cites this paper
• Targeting the tumor immwpune microenvironment with "nutraceuticals": From bench to clinical trials.

  2020cites this paper
• Targeting STAT proteins via computational analysis in colorectal cancer

  2020cites this paper
• Nutrition, Immunity, and Cancer

  2019cites this paper
• Dietary isoflavones, the modulator of breast carcinogenesis: Current landscape and future perspectives

  2018cites this paper
• The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

  2018cites this paper
• The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

  2018cites this paper
• The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

  2018cites this paper
• Metabolism and health effects of phyto-estrogens

  2017cites this paper
• Dietary Isoflavones and Breast Cancer Risk

  2017cites this paper
• Cancer and Chemoprevention: An Overview

  2017cites this paper
• Chemoprevention by Genistein

  2017cites this paper
• TNFRp55 deficiency promotes the development of ectopic endometriotic-like lesions in mice.

  2017cites this paper
• Role of Environmental Chemicals, Processed Food Derivatives, and Nutrients in the Induction of Carcinogenesis

  2015cites this paper
• Effects of oral exposure to bisphenol A on gene expression and global genomic DNA methylation in the prostate, female mammary gland, and uterus of NCTR Sprague-Dawley rats.

  2015cites this paper
• Supplemental genistein, quercetin, and resveratrol intake in active duty army soldiers.

  2015cites this paper
• ancer prevention and therapy through the modulation of the tumor icroenvironment

  2015cites this paper
• Cancer prevention and therapy through the modulation of the tumor microenvironment.

  2015cites this paper
• A multi-targeted approach to suppress tumor-promoting inflammation.

  2015cites this paper
• Engineered Versions of Granzyme B and Angiogenin Overcome Intrinsic Resistance to Apoptosis Mediated by Human Cytolytic Fusion Proteins

  2015cites this paper
• The immune system and inflammation in breast cancer.

  2014influential citation
• Supplemental Genistein, Quercetin, and Resveratrol Intake in Active Duty Army Soldiers

  2014cites this paper
• Harnessing the immune system for the treatment of breast cancer

  2014cites this paper
• Cell Death Regulates Injury and Inflammation During Renal Allograft Transplantation

  2014cites this paper
• Serine Protease Inhibitor-6 Inhibits Granzyme B–Mediated Injury of Renal Tubular Cells and Promotes Renal Allograft Survival

  2014cites this paper
• Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms

  2013cites this paper
• Improving the Therapeutic Potential of Human Granzyme B for Targeted Cancer Therapy

  2013cites this paper
• Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents.

  2012cites this paper
• Expression and function of serpinB9 in lung cancer cells

  2012influential citation
• Flavonoids in cancer prevention.

  2012cites this paper
• Genistein Stimulates MCF-7 Breast Cancer Cell Growth by Inducing Acid Ceramidase (ASAH1) Gene Expression*

  2011cites this paper
• Red clover and soy isoflavones—an in vitro safety assessment

  2011cites this paper
• Comparative studies on the interaction of genistein, 8-chlorogenistein, and 3',8-dichlorogenistein with bovine serum albumin.

  2011cites this paper
• Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overview

  2011cites this paper
• Etude du rôle des lymphocytes T régulateurs dans la régulation des réponses immunes antitumorales induites par vaccination

  2011cites this paper
• Inhibition of hepatoma 22 tumor by Liquiritigenin

  2010cites this paper
• Granzyme B-induced apoptosis in cancer cells and its regulation (review).

  2010cites this paper
• Genistein Induced Apoptotic Cell Death in Adult T-Cell Leukemia Cells through Estrogen Receptors

  2010cites this paper
• A Noncompetitive Small Molecule Inhibitor of Estrogen-regulated Gene Expression and Breast Cancer Cell Growth That Enhances Proteasome-dependent Degradation of Estrogen Receptor α*

  2010cites this paper
• Expression of proteinase inhibitor-9/serpinB9 in non-small cell lung carcinoma cells and tissues.

  2009cites this paper